The latest on managing care, value-based care, insurance markets, payers & providers

Headlines On Deadline...

I-Spy 2 is a new private-public collaboration that combines personalized medicine and novel clinical trial design to develop lifesaving new breast cancer drugs. It’s a partnership between heavy-hitters like the Food and Drug Administration, the National Institutes, and major pharmaceutical companies, and is led by the Foundation for the National Institutes of Health.... About 66 percent of the nearly 20 million state and local government employees were enrolled in employer-sponsored health plans in 2008, according to the Agency for Healthcare Research and Quality. In comparison, only 54 percent of private-sector workers were enrolled in their employers’ health plans.... A Swiss study suggests that implementing antibiotic treatment guidelines to treat infections that commonly occur in hospitals can change prescription practices and increase the appropriate use of antibiotics. The authors suggest that judicious use of antibiotics is essential, considering the growth of antimicrobial resistance and escalating costs in health care.

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.